Catheter-associated urinary tract infection and the Medicare rule changes.
about
Interventions to improve professional adherence to guidelines for prevention of device-related infectionsUrinary catheters: history, current status, adverse events and research agendaUreteral Stents and Foley Catheters-Associated Urinary Tract Infections: The Role of Coatings and Materials in Infection Prevention.Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing?A comparison of methods to detect urinary tract infections using electronic data.Management of catheter-associated urinary tract infection.A point prevalence cross-sectional study of healthcare-associated urinary tract infections in six Australian hospitalsPredicting hospital-acquired infections by scoring system with simple parametersIs the Centers for Medicare and Medicaid Service's lack of reimbursement for postoperative urinary tract infections in elderly emergency surgery patients justified?Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherenceHAC-POA policy effects on hospitals, other payers, and patients.Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trialA research framework for reducing preventable patient harmImplementation science: how to jump‐start infection prevention.Diagnosing inflammation and infection in the urinary system via proteomics.Epidemiology of hospital-acquired urinary tract-related bloodstream infection at a university hospital.Positive and negative spillovers of the Health Disparities Collaboratives in federally qualified health centers: staff perceptions.Preventing hospital-acquired infections: a national survey of practices reported by U.S. hospitals in 2005 and 2009Similar Neutrophil-Driven Inflammatory and Antibacterial Responses in Elderly Patients with Symptomatic and Asymptomatic BacteriuriaA prospective analysis of urinary tract infections among elderly trauma patients.Housestaff Knowledge Related to Urinary Catheter Use and Catheter-Associated Urinary Tract Infections.Predictors of hospital-acquired urinary tract-related bloodstream infection.Chief nursing officers' perspectives on Medicare's hospital-acquired conditions non-payment policy: implications for policy design and implementation.Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury.Do Foley Catheters Adequately Drain the Bladder? Evidence from CT Imaging StudiesIntroducing a population-based outcome measure to evaluate the effect of interventions to reduce catheter-associated urinary tract infection.Adoption of policies to prevent catheter-associated urinary tract infections in United States intensive care units.Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis.Preventing catheter-associated urinary tract infection in the United States: a national comparative study.Reducing inappropriate urinary catheter use: a statewide effort.Estimating hospital costs of catheter-associated urinary tract infectionGlycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC.Alterations in antibiotic susceptibility of urinary tract infection pathogens.Translating health care-associated urinary tract infection prevention research into practice via the bladder bundle.Approach to a positive urine culture in a patient without urinary symptoms.The Medicare policy of payment adjustment for health care-associated infections: perspectives on potential unintended consequencesIncluding catheter-associated urinary tract infections in the 2008 CMS payment policy: a qualitative analysis.Perceived impact of the Medicare policy to adjust payment for health care-associated infections.Hospital-acquired catheter-associated urinary tract infection: documentation and coding issues may reduce financial impact of Medicare's new payment policy.Silver nanoparticles-modified films versus biomedical device-associated infections.
P2860
Q24199084-768559FB-51E1-4602-9B2B-07E1C374A158Q26783479-FA01A54B-3902-4AF9-87B6-FFF89CB7A92EQ30387675-B9F7D862-E085-4724-82BA-280EBA41432DQ30416893-B79E1D0A-6E68-46F9-B3E8-EBE14C8B95C6Q33704169-0009050C-45FB-49F0-830B-42B021ABF3DFQ33834867-A2211665-2BEC-4DDF-9258-6C5696826DC6Q33996171-2663C12F-5590-4BF6-AC61-0B8AD8881934Q34009276-7918A40E-3224-4DBA-B9CA-E14157186BE5Q34251750-277B7BAF-1442-46E6-80DC-892811F4B756Q34346890-BBA82F13-627C-4F49-B04E-13276EB9E4EAQ34380473-ECD875AA-D672-41DB-A32D-9103536703E5Q34436765-CCF03EAE-8DBD-44C9-86A6-AFA25B454FB5Q34699187-AF6A3554-5C39-4BE1-8DEF-B545D56CE9CFQ34779990-F39BD1E5-6CF7-4878-A7C3-A6BE9D96D467Q35403048-D9BF8377-AACC-4FB4-9A4D-4C8344364EB8Q35414615-759F478D-361D-416B-BF02-49D2D82E457AQ36020811-9A6C20A6-C264-4E67-AB5C-F63F2B2E8C74Q36044098-717BEE82-5B59-433E-BD57-F702649B9D15Q36053469-EB22AC2F-0FC4-4491-B7C5-C524EB9DD2ACQ36091465-CC67238F-FE6D-41BF-891D-8658EB6B3042Q36190937-820FBEBC-8AF5-4F6B-8AF4-C89B28B471ECQ36235641-7696F275-D0DA-473D-898F-055FAD9CC7ADQ36402887-A86EB7A4-0739-4277-BC3F-2068694AB73FQ36437217-95A2A1B0-9D8A-4E9A-BF48-1A2584C01D9FQ36575970-4E4FA379-8559-45DC-AF88-D2869E8AEF9FQ36802966-F3656A09-E6D6-4B98-897F-A137C75F05B8Q36817963-ECC7EF56-21D9-4667-BCE3-2FC28D7D47C1Q36839689-BD1FD458-4769-403A-B2C8-634B04BA1F11Q36881023-22AB7711-C4C8-4D48-899F-7DE75E14184DQ37032184-E2154E98-604F-4B41-8BB8-DF72CAC4AE83Q37206276-9FB6C41F-3A9A-4538-BBD6-53B95B732DBDQ37260004-3B2EE21D-7CBB-43D5-BDF9-06E2CBDA67DCQ37455103-7989E272-DAD8-48DA-A526-C623DA3C17FDQ37468907-5B3F9B24-5F58-4471-9294-AD1374B2F5AFQ37550409-346461CE-EA39-4E59-A537-1D25082F35A5Q37721576-95637234-8747-4C31-A9D7-B7CB66FD81B7Q37721590-4AC28396-D9C8-4B70-9F1F-D6F48E6C7A79Q37721599-9EA3A383-27C7-40DE-B169-3042C192759EQ37738876-D966E1AE-70CD-44B6-A882-FCADA9AF5732Q37781763-B10E3168-58BF-46EF-BF0D-2A9AFCFFC1CB
P2860
Catheter-associated urinary tract infection and the Medicare rule changes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Catheter-associated urinary tract infection and the Medicare rule changes.
@ast
Catheter-associated urinary tract infection and the Medicare rule changes.
@en
Catheter-associated urinary tract infection and the Medicare rule changes.
@nl
type
label
Catheter-associated urinary tract infection and the Medicare rule changes.
@ast
Catheter-associated urinary tract infection and the Medicare rule changes.
@en
Catheter-associated urinary tract infection and the Medicare rule changes.
@nl
prefLabel
Catheter-associated urinary tract infection and the Medicare rule changes.
@ast
Catheter-associated urinary tract infection and the Medicare rule changes.
@en
Catheter-associated urinary tract infection and the Medicare rule changes.
@nl
P2093
P2860
P1476
Catheter-associated urinary tract infection and the Medicare rule changes
@en
P2093
Christine P Kowalski
David Calfee
Sanjay Saint
Sarah L Krein
P2860
P304
P356
10.7326/0003-4819-150-12-200906160-00013
P407
P577
2009-06-01T00:00:00Z